Aesculap AG

Works in Cardiovascular · Dermatology · Genetic & rare · GI & liver · Immunology · Infectious disease · Metabolic & endocrine · Musculoskeletal · Neurology · Oncology · Renal & urogenital · Respiratory · Women's health

Aesculap AG is a clinical trial sponsor. It has 28 active clinical trials with 8,812 planned participants, across 13 therapeutic areas. Since 2021 it has completed 40 trials and stopped 4 early.

Trial track record · since 2021

28Active trials8,812 planned participants
40Completed1 with results posted
4Stopped early9% of finished trials

Pipeline · 28 active trials

StageTrialStatus

Questions about Aesculap AG

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-11-06.

Approve Suite is not affiliated with Aesculap AG.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.